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Abstract
The formulation of global health policy is political; and all institutions operating in the global health landscape are 
political. This is because policies and institutions inevitably represent certain values, reflect particular ideologies, 
and preferentially serve some interests over others. This may be expressed explicitly and consciously; or implicitly 
and unconsciously. But it’s important to recognise the social and political dimension of global health policy. In 
some instances however, the politics of global health policy may be actively denied or obscured. This has been 
described in the development studies literature as a form of ‘anti-politics’. In this article we describe four forms of 
anti-politics and consider their application to the global health sector. 
Keywords: Global Health Policy, Global Health Governance, Politics, Anti-Politics 
Copyright: © 2014 by Kerman University of Medical Sciences
Citation:  McCoy D, Singh G. A spanner in the works? anti-politics in global health policy; Comment 






Received: 6 August 2014
Accepted:  21 August 2014
ePublished: 24 August 2014
Commentary
Full list of authors’ affiliations is available at the end of the article.
http://ijhpm.com
Int J Health Policy Manag 2014, 3(3), 151–153 doi 10.15171/ijhpm.2014.77
It seems extraordinary that we need reminding of the fact that policy-making is fundamentally political; and that there is no such thing as a ‘neutral policy’. If ‘politics’ 
describes how competing values, ideologies, and interests 
shape the way policies are formed and implemented, then 
there is little about ‘global health’ that is not political. 
In their paper, A ghost in the machine? politics in global health 
policy, Carlos Bruen and Ruairi Brugha remind us that 
“political and institutional factors are central to global health 
policy processes, down to and including the development and 
use of health evidence” (1). As such, they argue that politics is 
of fundamental importance to public health researchers; and 
that public health research itself is part of the political process 
of policy formulation. 
They describe how ‘politics’ cannot be separated from 
policy using three brief case studies of the World Health 
Organisation (WHO), the GAVI Alliance and the Global Fund 
to Fight Against AIDS, TB, and Malaria (GFATM). Bruen 
and Brugha’s take home message is that the politics of global 
health policy should be studied by public health researchers; 
and that we should add methodologies from the political and 
social sciences to the stock of more well-established public 
health research methods.
This is all good. It is important that we recognise and study 
the politics of global health institutions and policy, whilst 
simultaneously recognising that research and science are 
themselves fundamentally shaped by politics. But what can 
be said about the politics of global health, and what questions 
about it should global health researchers consider? Bruen and 
Brugha’s article provide some useful pointers.
For example, take their quotation of Richard Feachem’s 
description of the Global Fund as a “very apolitical 
organization... (where) we’ve been able to take principled and 
technical decisions which haven’t always been popular because 
we’re not subject to the political influences that would come to 
bear in the UN” (2).  At first glance, this is an uncontroversial 
statement. To be sure, the Global Fund is not handicapped 
by the difficulties and frustrations that come with the 
politics of multilateral UN governance. It is more focused, 
pragmatic and business-like; and being governed by a Board 
of individuals with shared aims and goals (which are also 
narrow and relatively uncontroversial), it can operate with 
much less ‘political’ interference. 
But this is not the same as saying that the Global Fund itself 
is not political, or that its creation was without controversy. 
In fact, the emergence of multiple global public-private 
partnerships (such as the Global Fund) as a new and alternative 
form of global health governance is hugely political – not least 
because it facilitated the growth in influence of private and 
corporate actors in global decision-making. Furthermore, the 
very construction of a multi-billion dollar fund to combat 
three diseases is itself the epitome of a narrow, selective, and 
disease-based approach to health and development which 
is profoundly shaped by particular social, historical, and 
political perspectives. 
But it is the choice to frame global health policy as apolitical 
that is worth exploring more. Is there, for example, a wish by 
some to actively depoliticise global health? And why do some 
actors frame global health priorities such as HIV/AIDS and 
child mortality in purely technical and operational terms that 
are set apart from any social and political context? 
Here it may be useful for global health researchers to consider 
some of the literature from the field of development studies 
which has explored the interface between politics and 
the business of development. One observation has been 
that development actors often self-identify themselves as 
technocrats who are located outside of politics. For example, 
Li describes the way in which social-political processes 
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are rendered ‘technical’ by development actors (3); while 
Ferguson describes how ‘development projects’ are often 
constructed and managed to actually ignore or avoid real 
world politics, often to the detriment of those projects (4). 
Similarly, Mosse describes the use of ‘mobilizing metaphors’ 
such as participation, ownership, capacity building, and good 
governance ‘to conceal ideological differences within the 
business of delivering development aid’ (5). 
A more critical and trenchant view is provided by Bebbington 
who notes how ‘anti-politics’ may be used as a tactic by which 
‘poverty discussions are increasingly separated from questions 
of distribution and social transformation, and in which poverty 
reduction becomes something sought through projects rather 
than political change’ (6). In such cases, being ‘anti-political’ 
or ‘apolitical’ is actually a very clear and deliberate political 
act in itself.
According to Schedler, there are four types of anti-politics (7). 
The first is an ‘instrumental anti-politics’ whereby political 
decisions are made by technocratic experts, often based on 
cost-benefit analyses that are projected as being rational 
and neutral. The second is an ‘amoral anti-politics’ in which 
the public domain is privatised, and people reduced to 
rational, utility-maximizing economic human beings whose 
interests and preferences are expressed through and derived 
from the market. The third is a ‘moral anti-politics’ which 
acts by reifying certain ‘normative positions’ and stifling 
democratic  or political debate through the labelling of any 
contrarian positions as being unethical, immoral, unpatriotic, 
or even treasonous. Finally, an ‘aesthetic anti-politics’ works 
by undermining educative, informative, and deliberative 
communication and debate, through the trivialising use of 
simplistic imagery, homilies, and symbolism. 
We see all four types of ‘anti-politics’ operating in global 
health. For example, instrumental and amoral anti-politics 
are reflected in various forms of health economics and 
were heavily promoted by the World Bank through health 
sector reform policy prescriptions in the 1980s and 1990s. 
Here, policies that denied rights to healthcare, and which 
institutionalised inequity and wrecked health systems, were 
dressed up as the outcome of a supposedly rational economic 
science and technocratic process of health planning. The 
moral and political context of debt and structural adjustment 
programmes were ignored by many health actors, as were 
the ideological assumptions and value judgements that 
underpinned economic evaluation and health systems policy. 
These forms of ‘anti-politics’ are perhaps less potent today. 
For example, there is a growing backlash against the false 
assumptions of mainstream academic economics as more 
people acknowledge that economics is fundamentally social, 
cultural, and political. That said, there is much of health 
economics and health systems policy that obscures the politics 
of competing belief systems, values, and interests. 
Moral and aesthetic forms of anti-politics, on the other 
hand, appear to be more prominent in global health these 
days. They parallel the rise in prominence of the ‘public-
private partnership’ and ‘corporate social responsibility’ 
paradigm in the global health sector, and which has grown 
significantly in force and influence with the support and 
encouragement of the Gates Foundation. Here we see an 
unquestioned acceptance of the participation of private and 
corporate actors in global agenda-setting and policy-making, 
and the tacit acceptance of a ‘philanthrocapitalist’ ideology 
and belief system. But any fundamental questioning of the 
ethics, appropriateness, legitimacy, and even efficiency of the 
emerging structures and systems of global health governance 
are frequently obstructed by the moral oratory of ‘saving 
lives’ and ‘fighting disease’. This rhetoric implies that any 
imperfections or deficiencies in ‘global health governance’ 
may be irrelevant or minor given the obvious ‘goodness’ of 
improving health. This tendency may run in tandem with the 
wish of many people to be apolitical or non-political simply 
because it is easier: take the money and ask no questions (no 
need to because you are saving lives).
Interestingly, a combination of amoral and aesthetic ‘anti-
politics’ are observable in the Global Fund’s approach to 
estimating the number of ‘lives saved’ by Global Fund 
supported programmes to provide AIDS and TB treatment, 
and to distribute malaria bednets (8). Apart from problems 
with the accuracy and reliability of the numbers calculated, the 
approach was criticised for taking attention away from other 
important investments such as health systems strengthening 
(which are not readily translated into a measure of  ‘saved lives’ 
or directly attributable to external aid agencies); reinforcing 
selective, vertical, and disease-based health programming; 
failing to produce any measure of efficiency; and ignoring 
the social determinants of the level of effectiveness of clinical 
interventions. However, these are easily ignored or rejected by 
the emotive rhetoric and irreproachable imagery associated 
with the saving of lives. 
But the temptation to be apolitical must be resisted. There 
is so much in global health policy that is both political and 
too important to ignore. For example, in the pharmaceutical 
sector, we need a better system for funding and governing 
research and development; and for advertising, prescribing, 
and selling medicines. But this will not happen unless we 
take a more critical look at intellectual property rights and 
the regulation of the pharmaceutical industry. And this in 
turn may require us to think about reducing the power and 
influence of the industry and delegitimising some of its 
harmful and unethical practices – not doing the opposite. 
More importantly, the global health community cannot afford 
to be apolitical: it is still the social determinants of health that 
predominantly shape the global experience of health and well-
being. Whether it is climate change, the threat of antibiotic 
resistance, the effects of war, conflict, and militarisation, or 
the corrosive effects of economic inequality on democracy, 
there is both a need and mandate for the global health 
community to be progressive, principled, and political. This 
need not come into conflict with the science of public health. 
Data, research, and evidence remain central to the formation, 
implementation, and monitoring of global health policy; but 
they can be misleading and false when viewed out of a social 
and political context. 
So what next for researchers interested in studying the politics 
of global health policy? There are many lines of enquiry that 
could be developed. One of them might involve applying 
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Schedler’s typology of anti-politics to a critical study of global 
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